JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended June 30, 2025.
SEOUL, South Korea, Aug. 6, 2025 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today its participation in K-Display 2025...
LOS ANGELES, Aug. 5, 2025 /PRNewswire/ -- As summer nights reach their peak, RayNeo, the forefront innovator in augmented reality (AR) technology, is thrilled to unveil...
TEMPE, Ariz., Aug. 4, 2025 /PRNewswire/ -- New independent UPLC laboratory testing has confirmed that Nootropics Depot's Tongkat Ali extracts are the industry's leading...
DELRAY BEACH, Fla., Aug. 1, 2025 /PRNewswire/ -- The global Suppositories Market, valued at US$1.56 billion in 2024 stood at US$1.63 billion in 2025 and...
The partnership aims to expand access to fresh food and enhance health outcomes in rural southwest Michigan food deserts
DETROIT, July 31, 2025 /PRNewswire/ -- Meridian...